Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
US8461157B2 · kind B2 · utility
22Cited by
5References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2011 |
| Grant date | Jun 11, 2013 |
| Priority date | — |
| Expiry date | May 6, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant application relates to deazapurines, thienopyrimidines and furopyrimidines with zinc-binding moiety based derivatives and their use in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.